Percutaneous coronary intervention of chronic total occlusion: A 5-year monocentric experience

##plugins.themes.academic_pro.article.main##

Selim Boudiche
Mouna Bader
Manel Abbassi
Zeynab Jebbari
Nadim Khader
Bassem Rekik
Fourat Zouari
Amal Ben Salem
Khaled Ezzaouia
Boutheina Besbes
Mohamed Chedly
Foued Daly
Rim Ben Rejeb
Faten El Ayech
Dhekra Sebki
Ines Bounaoues
Mehrez Gouader
Fathia Mghaieth
Sana Ouali
Noureddine Larbi
Manel Ben Halima
Mohamed Sami Mourali1

Abstract

Background: Chronic total occlusions (CTO) occurin 15-30% of coronaryangiogram, yetthischallenginglesionsubsetrepresentslessthan 10% of percutaneouscoronary interventions (PCI). Tunisian data are lacking. This study analyses a real-life Tunisian CTO-PCI immediate and long-termresults.


Methods: Single-center, observational retro-prospective study, between 2018 and 2023. Primaryendpointwas to assesstechnicalsuccess, major procedural complications, and targetlesionfailure (TLF) at 12-months. Secondaryendpointwas to identifyfactorsassociated to technicalfailure.


Results: 115 patients, 122 CTOslesions, 133 CTO-PCIs. Mean age 62±14.4 years. Gender-Ratio=6. Mean J-CTO score was 1.47±1.12. Dual injection (43.6%) and microcatheters (50.4%) wereunderused. Number of guidewires per procedurewas 2.35±1.12. Anterograde, retrograde and hybridapproacheswerenotedin 85%, 9% and 6%, respectively. Technicalsuccesswas 69.2% (of 133 procedures) and proceduralsuccesswas 73.0% (of 115 patients). Major complication rate stood at 3%. At 12 months, cardiovascularmortalitywas 7.0%, withoutdifferenceaccording to proceduralsuccess. TLF was 9.4% amongsuccessful CTO-PCIs. Associated factors to technicalfailurewere bifurcation involvement (OR=5.83 [1.7–20.1]; p=0.005), use of more than 4 guidewires per-procedure (OR=6.83 [1.6–28.7]; p=0.009), de-novo CTO (HR=8.43 [1.9–36.6]; p=0.004), previousattempts (OR=8.87 [1.8–43.6]; p=0.007), and no microcatheter use (OR=11.4 [3.5–36.8]; p=0.001).


Conclusion: This real-life studyfills a gap in Tunisian data on CTO-PCI outcomeswithtechnicalsuccess, complications and TLF rates comparable to thosereported in literature. 12-month survival rates weresimilarbetweensuccessful and failedprocedure groups.

Keywords:

Chronic total occlusion, Prognosis, Percutaneous coronary intervention, Technical success.

##plugins.themes.academic_pro.article.details##

References

  1. FeferP,KnudtsonML,CheemaAN,GalbraithPD,OsherovAB,YalonetskyS,etal.
  2. Current perspectives on coronary chronic total occlusions:the Canadian multicenter chronic
  3. total occlusions registry.JAmCollCardiol.2012Mar;59(11):991-7.
  4. AzzaliniL,JolicoeurEM,PighiM,MillánX,PicardF,TadrosVX,etal.²Epidemiology,
  5. management strategies,and out comes of patients with chronic tota lcoronary occlusion.AmJ
  6. Cardiol.2016Oct;118(8):1128-35.
  7. TsaiTT,StanislawskiMA,ShunkKA,Armstrong EJ,GrunwaldGK,SchobAH,etal.
  8. Contemporary incidence,management,andlong-term out comes of percutaneous coronary
  9. interventions for chronic coronary artery total occlusions.JACCCardiovascInterv.2017
  10. May;10(9):866-75.
  11. AbbottJD,KipKE,VlachosHA,SawhneyN,SrinivasVS,JacobsAK,etal.Recent
  12. trends in the percutaneous treatment of chronic total coronary occlusions.AmJCardiol.2006
  13. Jun;97(12):1691-6.
  14. RinfretS.Percutaneous intervention for coronary chronic total occlusion:the hybrid
  15. approach.Cham:Springer;2016.
  16. DehmerGJ,MirzaMA.The cost of percutaneous coronary intervention for chronic total
  17. occlusions in our current cost-conscious environment.JACCCardiovascInterv.2019
  18. Feb;12(4):332-4.
  19. SalisburyAC,KarmpaliotisD,GranthamJA,SapontisJ,MengQ,MagnusonEA,et al.
  20. In-hospital costs and costs of complications of chronic total occlusion angioplasty:insights
  21. fromtheOPEN-CTOregistry.JACCCardiovascInterv.2019Feb;12(4):323-31.
  22. LawtonJS,TamisHollandJE,BangaloreS,BatesER,BeckieT,BischoffJM,etal.
  23. ACC/AHA/SCAIguidelineforcoronaryarteryrevascularization:areportoftheAmerican
  24. collegeofcardiology/American heart association joint committee on clinical practice
  25. guidelines.Circulation.2022 Jan;145(3):18-114.
  26. NeumannFJ,SousaUvaM,AhlssonA,AlfonsoF,BanningAP,BenedettoU,etal.
  27. ESC/EACTSguidelines on myocardial revascularization .EurHeartJ.2019Jan;40(2):87-165.
  28. WernerGS,MartinYusteV,HildickSmithD,BoudouN,SianosG,GelevV,etal.A
  29. randomized multicentretrial to comparere vascularization with optimal medical therapy for the
  30. treatment of chronic total coronary occlusions. Eur Heart J.2018 Jul;39(26):2484-93.
  31. CardonaM,MartínV,PratGonzalezS,OrtizJT,PereaRJ,DeCaraltTM,etal.Benefits
  32. of chronic total coronary occlusion percutaneous intervention in patients with heart failure and
  33. reduced ejection fraction:insights from a cardiovascular magnetic resonance study.J
  34. CardiovascMagnReson. 2016Nov;18(1):78.
  35. IwamaM,TokoroF,TanakaS,MatsuokaR,KojimaT,YagasakiH,etal.Improvement
  36. of left ventricular function after successful chronic total occlusion recanalization in patients
  37. with evidence of ischemia by stress myocardial perfusion imaging.EurHeartJ.2013Aug;34
  38. Suppl 1:5335.
  39. SamyM,ElAwadyWS,AlDaydamonyMM,AbdElSameiMM,ShokryKA.
  40. Echocardiographic assessment of left ventricular function recovery post percutaneous coronary
  41. intervention of chronic total occlusions in patients with lowand mid-range left ventricular
  42. ejection fractions.Echocardiography.2020Feb;37(2):239-46.
  43. Toma A,GickM,MinnersJ,FerencM,ValinaC,LöffelhardtN,etal.Survivalafter
  44. percutaneous coronary intervention for chronic total occlusion.ClinResCardiol.2016
  45. Nov;105(11):921-9.
  46. AndreottiF,VrintsC,KoskinasKC,RosselloX,etal.2024ESCGuidelinesforthe
  47. diagnosis and management of chronic coronary syndromes .EurHeartJ.2024;45:3415–3537.
  48. doi:10.1093/eurheartj/ehae177.
  49. GalassiAR,VadalàG,WernerGS,CosynsB,SianosG,HillJ,etal.Evaluationand
  50. management of patients with coronary chronic total occlusions considered for revascularisation.
  51. A clinical consensus statement of the European Association of Percutaneous Cardiovascular
  52. Interventions(EAPCI)oftheESC,the European Association of Cardiovascular Imaging
  53. (EACVI)of the ESC,and the ESC Working Group on Cardiovascular Surgery.
  54. Euro Intervention.févr2024;20(3):e174‑84.
  55. YbarraLF,RinfretS,BrilakisES,KarmpaliotisD,AzzaliniL,GranthamJA,etal.
  56. Definitions and clinical trialde sign principles for coronary artery chronic total occlusion
  57. therapies:CTO-ARCconsensus recommendations.circulation.2021Feb;143(5):479-500.
  58. WernerG.Chronic total occlusions [Enligne].Mar2022[Consultéle29jan2024].
  59. Consultableàl’URL:https://www.pcronline.com/PCR-Publications/Textbooks/PCR-EAPCI-
  60. textbook/The-PCR-EAPCI-textbook-chapter-on-chronic-total-occlusions.
  61. IvanhoeRJ,WeintraubWS,DouglasJS,LemboNJ,FurmanM,GershonyG,etal.
  62. Percutaneous transluminal coronaryangioplasty of chronic total occlusions.primary success,
  63. restenosis,andlong-term clinical follow-up.Circulation.1992Jan;85(1):106-15.
  64. HafeezY,VargheseV.Chronic total occlusion of the coronary artery.StatPearls.[Enligne].
  65. Juil 2023 [Consulté le 29 jan 2024]. Consultable à l’URL:
  66. http://www.ncbi.nlm.nih.gov/books/NBK560507/
  67. Mario CD,Mashayekhi K,GarboR, Pyxaras S, Ciardetti N,WernerG.Recanalisation of
  68. coronary chronic total occlusions.Euro Intervention.2022Sep;18(7):535-61.
  69. WuEB,BrilakisES,MashayekhiK,TsuchikaneE,AlaswadK,ArayaM,etal.Global
  70. chronic total occlusion crossing algorithm.JAmColl Cardiol. 2021Aug;78(8):840-5.
  71. BrilakisES,GranthamJA,RinfretS,WymanRM,BurkeMN,KarmpaliotisD,etal.A
  72. percutaneous treatment algorithm for crossing coronary chronic total occlusions.JACC
  73. CardiovascInterv.2012Apr;5(4):367-79.
  74. VranckxP,CutlipDE,MehranR,LeonMB,SerruysPW.Consensus on definitions of
  75. clinical endpoints:percutaneous coronary and valvular intervention trials[Enligne]. Mai2021
  76. [Consultéle29jan2024].Consultableàl’URL:https://textbooks.pcronline.com/the-pcr-eapci-
  77. textbook/consensus-on-definitions-of-clinical-endpoints-percutaneous-coronary-and-valvular-
  78. intervention-trials
  79. KonstantinidisNV, WernerGS,DeftereosS,Di Mario C,GalassiAR,BuettnerJH, etal.
  80. Temporal trends in chronic total occlusion interventions in Europe.Circ CardiovascInterv.
  81. Oct;11(10):e006229.
  82. BenRomdhaneH,BenAliS,SkhiriH,TraissacP,BougatefS,MaireB,etal.Hypertension
  83. amongTunisian adults:results of theTAHINA project.HypertensRes.2012Mar;35(3):341-7.
  84. SapontisJ,SalisburyAC,YehRW,CohenDJ,HiraiT,LombardiW,etal.Early procedural
  85. and health status out comes after chronic total occlusion angioplasty: are port from theOPEN-
  86. CTO registry(outcomes,patient health status,and efficiency in chronic total occlusion hybrid
  87. procedures).JACCCardiovascInterv.2017Aug;10(15):1523-34.
  88. LeeSW,LeePH,AhnJM,ParkDW,YunSC,HanS,etal.Randomizedtrialevaluating
  89. percutaneous coronary intervention for the treatment of chronic total occlusion.Circulation.
  90. Apr;139(14):1674-83.
  91. AllanaSS,KostantinisS,SimsekB,KaracsonyiJ,AlaswadK,RempakosA,etal.
  92. Contemporary outcomes of chronic total occlusion interventions:update from the progress-cto
  93. (prospective global registry for the study of chronic total occlusion intervention) international
  94. registry.JAmCollCardiol.2023Mar;81Suppl 8:1040.
  95. HenriquesJS,HoebersLP,RåmunddalT,LaanmetsP,EriksenE,BaxM,etal.
  96. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the
  97. EXPLOREtrial.JAmCollCardiol.2016Oct;68(15):1622-32.
  98. KonstantinidisNV,WernerGS,DeftereosS,DiMarioC,GalassiAR,BuettnerJH,etal.
  99. Temporal trends in chronic total occlusion interventions in Europe.CircCardiovascInterv.
  100. Oct;11(10):e006229.
  101. MashayekhiK,NührenbergTG,TomaA,GickM,FerencM,HochholzerW,etal.A
  102. randomized trial to assess regional left ventricular function after stent implantation in chronic
  103. total occlusion:the REVASCTrial.JAmCollCardiolIntv.2018Oct;11(19):1982-91.
  104. GhazzalZ,SawayaF.In-stentCTOPCI:anexpanding horizon.JACCCardiovascInterv.
  105. Jun;14(12):1320-2.
  106. ChristopoulosG,KarmpaliotisD,AlaswadK,LombardiWL,GranthamJA,RanganBV,
  107. etal.Theefficacyof“hybrid”percutaneous coronary intervention in chronic total occlusions
  108. caused by in-stent restenosis: Insights from a US multicenterregistry.CatheterCardiovasc
  109. Interv.2014Oct;84(4):646-51.
  110. LefèvreT,PanM,StankovicG,OjedaS,BoudouN,BrilakisES,etal.CTOandbifurcation
  111. lesions.JACCCardiovascInterv.2023Sep;16(17):2065-82.
  112. QuintanaB,IbrahimA.Roleofintravascularultrasoundinguidingcomplexpercutaneous
  113. coronaryinterventions.USCardiol.2020 Jun;14:e07.
  114. MorinoY,AbeM,MorimotoT,KimuraT,HayashiY,MuramatsuT,etal.Predicting
  115. successful guide wire crossing through chronic total occlusion of native coronary lesions with in
  116. minutes.JACCCardiovascInterv.2011Feb;4(2):213-21.
  117. GalassiAR,SianosG,WernerGS,EscanedJ,TomaselloSD,BoukhrisM,etal.Retrograde
  118. recanalization of chronic total occlusions in Europe:procedural,in-hospital,andlong-term
  119. outcomesfromthemulticenterERCTOregistry.JAmCollCardiol.2015Jun;65(22):2388-400.
  120. KalogeropoulosA,AlsanjariO,KeebleTR,TangKH,KonstantinouK,KatsikisA,etal.
  121. CASTLEscoreversusJ-CTO score for the prediction of technical success in chronic total
  122. occlusion percutaneous revascularisation.EuroIntervention.2020Apr;15(18):1615-23.
  123. BrilakisES,MashayekhiK,TsuchikaneE,RafehNA,AlaswadK,ArayaM,etal.Guiding
  124. principles for chronic total occlusion percutaneous coronary intervention.Circulation.2019
  125. Jul;140(5):420-33.
  126. TsuchikaneE,KatohO,KimuraM,NasuK,KinoshitaY,SuzukiT.The first clinical
  127. experience with an ovel catheter for collateral channel tracking in retrograde approach for
  128. chronic coronary total occlusions.JAmCollCardiolIntv.2010Feb;3(2):165-71.
  129. KostantinisS,SimsekB,KaracsonyiJ,AlaswadK,JafferFA,KhatriJJ,etal.Equipment
  130. utilization in chronic total occlusion percutaneous coronary interventions:insights from the
  131. progress-ctoregistry.JAmCollCardiol.2023Mar;81Suppl8:780.
  132. AlexandrouM,RempakosA,MutluD,OgailiAA,ChoiJW,PoommipanitP,etal.
  133. Comparative analysis of polymerversusnon-polymerjacketedwires in chronic total occlusion
  134. percutaneous coronary intervention.AmJCardiol.2024 Mar;215:10-8.
  135. IannacconeG,ScarparoP,WilschutJ,DaemenJ,DekkerWD,JaegerePD,etal.Current
  136. approaches for treatment of coronary chronic occlusions.Expert RevMedDevices.2019
  137. Nov;16(11):941-54.
  138. RempakosA,KostantinisS,SimsekB,KaracsonyiJ,ChoiJW,PoommipanitP,etal.
  139. Outcomes of chronic total occlusion percutaneous coronary intervention after a previous failed
  140. attempt.AmJ Cardiol.2023Apr;193:61-9.
  141. RileyRF,HenryTD.CTOPCI:whenatfirstyoudon’tsucceed…CatheterCardiovasc
  142. Interv.2019Oct;94(4):525-6.